Prevalence and Burden of Chronic Migraine in Adolescents: Results of the Chronic Daily Headache in Adolescents Study (C-dAS)

被引:117
作者
Lipton, Richard B. [1 ,2 ]
Manack, Aubrey [3 ]
Ricci, Judith A. [4 ]
Chee, Elsbeth [4 ]
Turkel, Catherine C. [3 ]
Winner, Paul [5 ,6 ]
机构
[1] Albert Einstein Coll Med, Bronx, NY 10467 USA
[2] Montefiore Headache Ctr, Bronx, NY USA
[3] Allergan Pharmaceut Inc, Irvine, CA 92715 USA
[4] CVS Caremark, Hunt Valley, MD USA
[5] Palm Beach Neurol Premiere Res Inst, W Palm Beach, FL USA
[6] Palm Beach Headache Ctr, W Palm Beach, FL USA
来源
HEADACHE | 2011年 / 51卷 / 05期
关键词
adolescent; chronic daily headache; chronic migraine; epidemiology; classification; burden of illness; DISABILITY; POPULATION; DIAGNOSIS; RELIABILITY; PATTERNS; ILLNESS;
D O I
10.1111/j.1526-4610.2011.01885.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective.- To estimate the prevalence of chronic migraine (CM) among adolescents and to describe the epidemiologic profile, headache characteristics, disability, and healthcare utilization of adolescents with CM in the USA. Background.- Chronic daily headache (CDH) and CM occur in children and adolescents, but are poorly understood in these populations because their presentation is different from that in adults. It may be difficult to assign a definitive diagnosis to young people suffering from CDH because symptoms may fail to meet the criteria for one of the CDH subtypes. Methods.- A large sample of households with at least one resident aged 12 to 19 years was selected in balance with the US Census. Data were collected in 3 phases: (1) mailed questionnaire; (2) telephone interview; and (3) 30-day interactive voice response system diary. CM prevalence was estimated by adapting the second edition of the International Classification of Headache Disorders criteria for CM to include pediatric migraine diagnostic criteria. The population was stratified for medication overuse. Medication overuse was defined as 15 or more days per month of acute medication use. Included in the study were measures of headache characteristics, headache impact (Headache Impact Test), disability (Pediatric Migraine Disability Assessment), and healthcare and medication use. Data are reported on subjects 12 to 17 years of age only. Results.- The US adolescent (12-17 years) prevalence rate for CM was 0.79% (0.00-1.70) excluding those with medication overuse and 1.75% (0.62-2.89) when adolescents with medication overuse were included. The majority of adolescents with CM had Headache Impact Test scores greater than or equal to 60, indicating severe headache impact, and mean Pediatric Migraine Disability Assessment scores greater than 17, indicating severe headache and disability. The majority of adolescents with CM (approximately 60%) had not visited a healthcare provider in the previous year and less than one in 5 reported taking medications to prevent headaches during the last month. Conclusions.- Results suggest that CM occurs less frequently in adolescents than adults, but like adults, adolescents are severely burdened by the disorder. Data support an unmet medical need; however, the development of optimal criteria for diagnosing adolescents with CM is critical to fully understanding how medical needs can be met within this complex population.
引用
收藏
页码:693 / 706
页数:14
相关论文
共 25 条
[1]   Brainstem dysfunction in chronic migraine as evidenced by neurophysiological and positron emission tomography studies [J].
Aurora, Sheena K. ;
Barrodale, Patricia M. ;
Tipton, Reda L. ;
Khodavirdi, Ani .
HEADACHE, 2007, 47 (07) :996-1003
[2]   Spectrum of illness Understanding biological patterns and relationships in chronic migraine [J].
Aurora, Sheena K. .
NEUROLOGY, 2009, 72 (05) :S8-S13
[3]   Recommendations for the management of migraine in paediatric patients [J].
Balottin, Umberto ;
Termine, Cristiano .
EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (06) :731-744
[4]  
Bayliss M., 2002, The HIT-6: a user's guide
[5]   Chronic migraine in the population - Burden, diagnosis, and satisfaction with treatment [J].
Bigal, Marcelo E. ;
Serrano, Daniel ;
Reed, Michael ;
Lipton, Richard B. .
NEUROLOGY, 2008, 71 (08) :559-566
[6]   The differential diagnosis of chronic daily headaches: An algorithm-based approach [J].
Bigal M.E. ;
Lipton R.B. .
The Journal of Headache and Pain, 2007, 8 (5) :263-272
[7]   Primary chronic daily headache and its subtypes in adolescents and adults [J].
Bigal, ME ;
Lipton, RB ;
Tepper, SJ ;
Rapoport, AM ;
Sheftell, FD .
NEUROLOGY, 2004, 63 (05) :843-847
[8]   Migraine days decline with duration of illness in adolescents with transformed migraine [J].
Bigal, ME ;
Sheftell, FD ;
Tepper, SJ ;
Rapoport, AM ;
Lipton, RB .
CEPHALALGIA, 2005, 25 (07) :482-487
[9]   Disability, HRQoL and resource use among chronic and episodic migraineurs: Results from the International Burden of Migraine Study (IBMS) [J].
Blumenfeld, A. M. ;
Varon, S. F. ;
Wilcox, T. K. ;
Buse, D. C. ;
Kawata, A. K. ;
Manack, A. ;
Goadsby, P. J. ;
Lipton, R. B. .
CEPHALALGIA, 2011, 31 (03) :301-315
[10]   Patterns of diagnosis and acute and preventive treatment for migraine in the United States: Results from the American Migraine Prevalence and Prevention study [J].
Diamond, Seymour ;
Bigal, Marcelo E. ;
Silberstein, Stephen ;
Loder, Elizabeth ;
Reed, Michael ;
Lipton, Richard B. .
HEADACHE, 2007, 47 (03) :355-363